title: [Malignant-like neuroleptic syndrome: a sign to call attention to].
authors.forename: A
authors.initials: A
authors.lastname: Segado Soriano
authors.forename: J
authors.initials: J
authors.lastname: García Castaño
authors.forename: J
authors.initials: J
authors.lastname: del Toro Cervera
authors.forename: A
authors.initials: A
authors.lastname: Muiño Miguez
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage; D001971:Bromocriptine / Q000008:administration & dosage; D002511:Cephalosporins / Q000008:administration & dosage; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000209:etiology; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy
chemical_list: D000978:Antiparkinson Agents; D002511:Cephalosporins; D001971:Bromocriptine; D007980:Levodopa